Otsuka Pharmaceutical has agreed to acquire Canada-based Daiya Foods which specializes in the manufacturing plant-based foods. The acquisition, reported at 405 million Canadian dollars, is expected to help increase Daiya's presence ...
Tags: Otsuka, plant-based foods
Otsuka Pharmaceutical and H. Lundbeck have announced marketing authorization approval from the European Commission for Abilify Maintena (aripiprazole), an intramuscular (IM) once-monthly injectable formulation for maintenance treatment of ...
H Lundbeck has expanded its current alliance with Otsuka Pharmaceutical (Otsuka) to include development and commercialization of nalmefene in Japan. Earlier in 2013, nalmefene was approved by the European Medicines Agency (EMA) as the ...
Tags: Lundbeck, Otsuka Pharmaceutical
US-based natural beverage firm Crystal Geyser Water (CGWC) has acquired a bottling facility located on 266 acres in Mount Shasta, California. With its new 145,000ft2 bottling facility, the company will be able to meet the rising demands ...
Tags: Crystal Geyser, Bottling Facility
Danish pharmaceutical company H. Lundbeck and Japanese drugmaker Otsuka Pharmaceutical have announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended marketing approval for ...
Japanese drugmaker Otsuka Pharmaceutical has agreed to acquire Astex Pharmaceuticals for $866m in an all-cash tender offer. Under the deal, Astex's fragment-based drug design technology called 'PYRAMID' will be integrated into Otsuka, ...
Otsuka Pharmaceutical has established a new company named Otsuka Europe Development and Commercialisation Ltd. (OEDC) for the development of pharmaceuticals in the UK. Working in conjunction with Otsuka Pharmaceutical Europe (OPEL), OEDC ...
Tags: Pharmaceutical Development, Otsuka
Pharmavite, a US-based manufacturer of vitamins, minerals and other dietary supplements, has announced the official opening of its new manufacturing facility at the Northeast Opelika Industrial Park in Opelika, Alabama. The establishment ...
Tags: Pharmavite, minerals
The USFDA has accepted Otsuka Pharmaceutical's new drug application (NDA) of tolvaptan for priority review to treat autosomal dominant polycystic kidney disease (ADPKD). The filing was based on Phase III clinical trial results of the drug ...
Tags: Otsuka Tolvaptan NDA, Medicine
Catalent has started supplying its antipsychotic drug, Abilify, an orally disintegrating tablet (ODT) to Otsuka Pharmaceutical. Abilify ODT, which utilizes Catalent's Zydis fast dissolve drug delivery technology, is designed to improve ...
Tags: Catalent, Abilify Antipsychotic Drug, Otsuka Pharma, antipsychotic drug